CT26.WT In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1122-YF1152
Target Cell Organism: Mouse
Target Cell Alternative Name: CT26
Target Cell Name: CT26.WT
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide CT26.WT-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
CT26.WT
Target Cell Organism
Mouse
Target Cell Background
CT26 is an N-nitroso-N-methylurethane-(NNMU) induced, undifferentiated colon carcinoma cell line. It was cloned to generate the cell line designated CT26.WT. Use CT26.WT mouse fibroblasts with CT26.CL25 as a model for testing immunotherapy protocols and in studies on the host immune response.
Target Cell Alternative Name
CT26
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
CT26.WT-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry